Micofenolato o tacrolimus comparado con ciclofosfamida en el tratamiento de nefritis lúpica: revisión sistemática y metaanálisis

Patients treated with MF, tacrolimus and CY have similar rates of remission; however there is greater benefit in outcome response when comparing tacrolimus and CY. Comparing MF with CY showed a lower risk of menstrual abnormalities and reduced risk of alopecia.